NASDAQ : STAA
STAAR Surgical Company — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 25.24 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.27B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.25B |
| Enterprise Value | 1.11B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 50.14M |
| Shares Outstanding | 50.14M |
| Shares Change (YoY) | +2.37% |
| Shares Change (QoQ) | +1.18% |
| Owned by Insiders (%) | 0.89% |
| Owned by Institutions (%) | 60.31% |
| Float | 26.12M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 324.24 |
| Forward PE | 25.27 |
| PS Ratio | 3.69 |
| Forward PS | 3.56 |
| PB Ratio | 3.37 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 288.24 |
| EV / Sales | 3.26 |
| EV / EBITDA | 22.24 |
| EV / EBIT | 26.82 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.66 |
| Quick Ratio | 3.86 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.09% |
| Return on Assets (ROA) | 5.65% |
| Return on Invested Capital (ROIC) | 4.09% |
| Return on Capital Employed (ROCE) | 10.27% |
| Weighted Average Cost of Capital (WACC) | 10.43% |
| Revenue Per Employee | $368,719 |
| Profits Per Employee | $4,168 |
| Employee Count | 921 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.59 |
Taxes
| Measure | Value |
|---|
| Income Tax | 13.54M |
| Effective Tax Rate | 77.91% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -3.40% |
| 50-Day Moving Average | 22.45 |
| 200-Day Moving Average | 23.62 |
| Relative Strength Index (RSI) | 63.98 |
| Average Volume (20 Days) | 575,064 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.70M |
| Short Previous Month | 3.74M |
| Short % of Shares Out | 7.37% |
| Short % of Float | 14.15% |
| Short Ratio (days to cover) | 3.76 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 339.59M |
| Gross Profit | 260.20M |
| Operating Income | 41.26M |
| Pretax Income | 17.38M |
| Net Income | 3.84M |
| EBITDA | 49.76M |
| EBIT | 41.26M |
| Earnings Per Share (EPS) | $0.08 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 181.49M |
| Total Debt | 35.94M |
| Net Cash | 145.55M |
| Net Cash Per Share | $2.90 |
| Equity (Book Value) | 365.40M |
| Book Value Per Share | 7.29 |
| Working Capital | 268.96M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -3.25M |
| Capital Expenditures | -3.50M |
| Depreciation & Amortization | 8.50M |
| Net Borrowing | n/a |
| Free Cash Flow | -6.75M |
| FCF Per Share | -$0.13 |
Margins
| Measure | Value |
|---|
| Gross Margin | 76.62% |
| Operating Margin | 12.15% |
| Pretax Margin | 5.12% |
| Profit Margin | 1.13% |
| EBITDA Margin | 14.65% |
| EBIT Margin | 12.15% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.37% |
| Shareholder Yield | -2.37% |
| Earnings Yield | 0.31% |
| FCF Yield | -0.54% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $27.67 |
| Price Target Difference | 10.95% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 17.58% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 18, 1992 |
| Split Type | Reverse |
| Split Ratio | 1:2 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 7.83 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |